James Leif Smith
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$4.2MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 5, 2024 | NIH | STTR Phase II Preclinical Development of Occidiofungin for Treatment of Oral and Dermal Candidiasis | $300K | SANO CHEMICALS, INC |
| Apr 27, 2021 | NIH | STTR Phase II Preclinical Development of OCF001 for Treatment of Yeast Infections | $931K | SANO CHEMICALS, INC |
| Aug 11, 2020 | NIH | STTR Phase I A Novel Therapeutic Agent for the Treatment of Gram-positive Infections | $233K | SANO CHEMICALS, INC |
| Apr 16, 2020 | NIH | STTR Phase II Preclinical Development of OCF001 for Treatment of Yeast Infections | $966K | SANO CHEMICALS, INC |
| Mar 21, 2019 | NIH | STTR Phase II Preclinical Development of OCF001 for Treatment of Yeast Infections | $983K | SANO CHEMICALS, INC |
| Feb 17, 2017 | NIH | STTR Phase I Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin | $234K | SANO CHEMICALS, INC |
| Feb 14, 2017 | NIH | STTR Phase I Lead Compound Discovery from Engineered Analogs of Occidiofungin | $225K | SANO CHEMICALS, INC |
| Mar 11, 2016 | NIH | STTR Phase I Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin | $295K | SANO CHEMICALS, INC |
Peer ranks
Federal funding#367
Awards as PI#190
Patents#273
Companies
- SANO CHEMICALS, INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.